Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Adams

Showing results (811-820 of 831) with videos related to

Pageof 84
Sort By:
Scientific Reports|February 27, 2015
Phenotypic population screen identifies a new mutation in bovine DGAT1 responsible for unsaturated milk fatKlaus Lehnert, Hamish Ward, Sarah D Berry, et al.
JAMA|July 11, 2013
Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiariesDaniel D Matlock, Peter W Groeneveld, Steve Sidney, et al.
JACC. Heart Failure|March 7, 2023
Omecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction: Insights From GALACTIC-HFDavid E Lanfear, Joyce N Njoroge, Kirkwood F Adams, et al.
Journal of Periodontology|March 1, 2000
The effect of locally delivered controlled-release doxycycline or scaling and root planing on periodontal maintenance patients over 9 monthsS Garrett, D F Adams, G Bogle, et al.
Lancet (London, England)|November 13, 2012
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialJohn R Teerlink, Gad Cotter, Beth A Davison, et al.
Journal of the American College of Cardiology|January 1, 2013
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomesMarco Metra, Gad Cotter, Beth A Davison, et al.
Journal of Cardiac Failure|September 8, 2023
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HFKieran F Docherty, John J V McMurray, Rafael Diaz, et al.
Journal of Periodontology|January 5, 2002
Treatment of periodontitis by local administration of minocycline microspheres: a controlled trialR C Williams, D W Paquette, S Offenbacher, et al.
Journal of Periodontology|June 15, 1999
Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitisS Garrett, L Johnson, C H Drisko, et al.
European Journal of Heart Failure|January 4, 2023
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trialKieran F Docherty, John J V McMurray, Brian L Claggett, et al.
Pageof 84

Showing results (811-820 of 831) with videos related to

Sort By:
Pageof 84
Scientific Reports|February 27, 2015
Phenotypic population screen identifies a new mutation in bovine DGAT1 responsible for unsaturated milk fatKlaus Lehnert, Hamish Ward, Sarah D Berry, et al.
JAMA|July 11, 2013
Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiariesDaniel D Matlock, Peter W Groeneveld, Steve Sidney, et al.
JACC. Heart Failure|March 7, 2023
Omecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction: Insights From GALACTIC-HFDavid E Lanfear, Joyce N Njoroge, Kirkwood F Adams, et al.
Journal of Periodontology|March 1, 2000
The effect of locally delivered controlled-release doxycycline or scaling and root planing on periodontal maintenance patients over 9 monthsS Garrett, D F Adams, G Bogle, et al.
Lancet (London, England)|November 13, 2012
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trialJohn R Teerlink, Gad Cotter, Beth A Davison, et al.
Journal of the American College of Cardiology|January 1, 2013
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomesMarco Metra, Gad Cotter, Beth A Davison, et al.
Journal of Cardiac Failure|September 8, 2023
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HFKieran F Docherty, John J V McMurray, Rafael Diaz, et al.
Journal of Periodontology|January 5, 2002
Treatment of periodontitis by local administration of minocycline microspheres: a controlled trialR C Williams, D W Paquette, S Offenbacher, et al.
Journal of Periodontology|June 15, 1999
Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitisS Garrett, L Johnson, C H Drisko, et al.
European Journal of Heart Failure|January 4, 2023
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: insights from the GALACTIC-HF trialKieran F Docherty, John J V McMurray, Brian L Claggett, et al.
Pageof 84